IMMRAY
LIVE

Serial Number

79176421

Owner

Immunovia AB

Attorney

Susan Neuberger Weller

Filing Date

Aug 24, 2015

Add to watchlist:

No watchlists yet
View on USPTO

IMMRAY Trademark

Serial Number: 79176421 • Registration: 5202108

IMMRAY is a trademark filed by Immunovia AB on August 24, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Immunovia AB (3 trademarks)

Scheelevägen 2, Medicon Village
Lund SE-223 81 , SE

Entity Type: 03

Trademark Details

Filing Date

August 24, 2015

Registration Date

May 16, 2017

Published for Opposition

February 28, 2017

Cancellation Date

August 24, 2025

Goods & Services

Performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; performing diagnosis of cancer and auto-immune diseases

Sanitary preparations for medical use; biological indicators for medical diagnosis; diagnostic preparations for medical purposes; diagnostic reagents for medical use; chemical reagents for medical purposes for the diagnosis of cancer and auto-immune diseases

Medical apparatus and instruments for diagnostic, prognostic patient stratification, examination and monitoring purposes, namely, apparatus for multiplex measuring of proteins in blood; diagnostic apparatus for medical purposes for diagnosing cancer and auto-immune diseases; sensor apparatus for medical use in diagnosis for diagnosing cancer and auto-immune diseases; apparatus for carrying-out diagnostic tests for medical purposes for diagnosing cancer and auto-immune diseases; medical diagnostic apparatus for detecting cancer and auto-immune diseases; DNA microarray for use in medical research for medical purposes for the diagnosis of cancer and auto-immune diseases; blood testing analyzers for medical purposes for the diagnosis of cancer and auto-immune diseases

Medical research services; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the area of pancreatic cancerous diseases; scientific research for medical purposes in the area of breast cancerous diseases; scientific research for medical purposes in the area of prostate cancerous diseases; scientific research for medical purposes in the area of auto-immune diseases; providing computer aided medical testing services, namely, computer aided blood analysis services in the field of cancer and auto-immune diseases research; research and development of computer software

Computer software for diagnosis of disease; Computer software for diagnosing of cancer diseases; Computer software for diagnosing of pancreatic cancer; Computer software for diagnosing of breast cancer; Computer software for diagnosing of prostate cancer; Computer software for diagnosing of auto-immune diseases; DNA chips

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Mar 19, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Mar 19, 2026 DETH
NEW REPRESENTATIVE AT IB RECEIVED
Mar 7, 2025 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 4, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Jan 4, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 3, 2024 APRE
TEAS SECTION 71 RECEIVED
May 4, 2023 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 16, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 29, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 17, 2017 FICS
FINAL DISPOSITION PROCESSED
Aug 17, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 16, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
May 16, 2017 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 5, 2017 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 19, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 19, 2017 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2017 NPUB
PUBLISHED FOR OPPOSITION
Feb 28, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Feb 24, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 8, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 8, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 8, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 24, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 16, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 16, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 16, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 16, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 16, 2017 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 19, 2016 GNFN
FINAL REFUSAL E-MAILED
Jul 19, 2016 GNFR
FINAL REFUSAL WRITTEN
Jul 19, 2016 CNFR
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jun 28, 2016 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 28, 2016 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2016 CRFA
ASSIGNED TO LIE
Jun 18, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 10, 2016 TROA
REFUSAL PROCESSED BY IB
Jan 4, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 11, 2015 RFCS
REFUSAL PROCESSED BY MPU
Dec 10, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 9, 2015 RFCR
NON-FINAL ACTION WRITTEN
Dec 8, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 8, 2015 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 25, 2015 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 19, 2015 REPR